Nafcillin
From Wikipedia, the free encyclopedia
![]() |
|
Nafcillin
|
|
Systematic (IUPAC) name | |
7-[(2-ethoxynaphthalen-1-yl) carbonylamino]- 3,3-dimethyl-6-oxo-2-thia-5-azabicyclo [ 3.2.0] heptane-4-carboxylic acid | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C21H22N2O5S |
Mol. mass | 414.476 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Protein binding | 90% |
Metabolism | <30% hepatic |
Half life | ? |
Excretion | Biliary and renal |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | Oral, IM, IV |
Nafcillin sodium is a beta-lactam antibiotic of the penicillin class. As a beta-lactamase-resistant penicillin, it is used to treat infections caused by Gram-positive bacteria, particularly species of Staphylococci, that are resistant to other penicillins.
[edit] Administration
Nafcillin can be given either orally (trade name Unipen®) or by injection (Nallpen®)
[edit] Side effects
As with all penicillins, serious life-threatening allergic reactions can occur.
Milder side effects include:
- Nausea and vomiting
- Diarrhea, often due to suppression of normal gastrointestinal bacteria. Occasionally, this leads to a more serious super-infection with an organism like Clostridium difficile
- Abdominal pain
- Yeast infections (thrush) affecting the mouth and tongue or vagina